Potassium Iodide for Cutaneous Inflammatory Disorders: A Monocentric, Retrospective Study

Anzengruber, Florian; Mergenthaler, Caroline; Murer, Christian; Dummer, Reinhard

doi:10.1159/000494614

Cited by 10 publications

(4 citation statements)

References 25 publications

(36 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Potassium iodide (KI) is another treatment that has been suggested for GA, although recent studies yield disappointing results. An 11-patient retrospective study found that KI led to improvement in only four patients [ 94 ]. Furthermore, in the retrospective study by Nordmann et al, of the 12 patients treated with KI, none experienced complete resolution, three experienced partial resolution, two had stable disease, and two had GA progression [ 59 ].…”

Section: Review Of Management Optionsmentioning

confidence: 99%

Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options

Joshi

Duvic

2021

Am J Clin Dermatol

View full text Add to dashboard Cite

Granuloma annulare (GA) is an inflammatory granulomatous skin disease that can be localized (localized GA) or disseminated (generalized GA), with patch, perforating, and subcutaneous subtypes being less common variants of this benign condition. Recently, new research has emerged that further elucidates GA epidemiology and etiopathogenesis; importantly, new therapeutic options for GA have also been described, although there remains a paucity of randomized controlled studies. In this review, we summarize recent updates on GA epidemiology and etiopathogenesis and offer an updated review of the therapeutic options for GA currently reported in the literature. We hope that the current review galvanizes randomized controlled studies that will in turn help lead to the recommendation of evidence-based treatments for GA.

show abstract

Section: Review Of Management Optionsmentioning

confidence: 99%

Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options

Joshi

Duvic

2021

Am J Clin Dermatol

View full text Add to dashboard Cite

show abstract

“…also highlighted a disappointing response to dapsone, with only three of seven patients noting improvement. Anzengrueber et al 25 . show poor response of NL to potassium iodide, with only two of seven patients noting amelioration.…”

Section: Discussionmentioning

confidence: 97%

“…Anzengrueber et al 25 show poor response of NL to potassium iodide, with only two of seven patients noting amelioration.…”

Section: Groupmentioning

confidence: 96%

Treatment options for necrobiosis lipoidica: a systematic review

Nihal,

Caplan,

Rosenbach

et al. 2023

Int J Dermatology

View full text Add to dashboard Cite

BackgroundNecrobiosis lipoidica (NL) is a rare, idiopathic, and recalcitrant disease of collagen degeneration for which treatment options have been poorly studied. Due to its recurring nature, risk for ulceration, and high morbidity, there is a need to understand existing treatment modalities to better inform clinical care.ObjectiveThis review aims to describe the therapeutic modalities reported in the literature for the treatment of NL.MethodsA literature search of treatments was performed by searching for publications between January 2016 and May 2022 on PubMed and Scopus. Given the limited high‐quality evidence, case reports and series were included. Only publications presenting information on both attempted treatments and outcomes were included.ResultsA total of 60 novel articles were identified (54 case reports, two case series, and four retrospective cohort studies). These studies cumulatively reported on 274 patients and covered treatments including phototherapy, topical corticosteroids, topical calcineurin inhibitors, biologics, immunosuppressants, JAK inhibitors, combination therapies, and several others. The greatest amount of evidence was found for photodynamic therapy (improvement in 72 of 80 patients), UVA‐based phototherapy (12 of 33), topical corticosteroids (21 of 46), compression therapy (15 of 20), and topical calcineurin inhibitors (11 of 17). Several newer treatments were also described, including ustekinumab and JAK inhibitors.ConclusionsThis systematic review provides a comprehensive summary of recently published treatments for NL. As the existing data comes predominantly from case reports and series, statistical conclusions are not assessed. A greater number of randomized controlled trials with standardized endpoints are necessary to compare treatment efficacy.

show abstract

“…Options include NSAIDs such as indomethacin or naproxen 2 3 Additionally potassium iodide has been reported to be effective in ENM treatment with lesions clearing within a few weeks, however its role in inflammatory dermatoses maybe over-estimated. 4 Colchicine is an anti-inflammatory agent demonstrated to be effective in the treatment of nodular vasculitis where neutrophils maybe present histologically 5 and has been used in the treatment erythema nodosum. 6 Colchicine plays a role in reducing neutrophil chemotaxis and degranulation, which may explain the effectiveness in ENM treatment.…”

mentioning

confidence: 99%